HIF-1
HIF-1
批准号:
7359134
负责人:
ERICA A. GOLEMIS
金额:
$8.13万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2007-07-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The shape of a cell is determined primarily by its internal actin cytoskeletal architecture and influenced by focal adhesions, which constitute points of linkage between the extracellular matrix (ECM), the integrin receptor system and actin scaffolds. In response to external adhesive signals or internally generated cues, cells rearrange their actin cytoskeletal networks, thereby altering assembly of integrin-associated signal-transducing networks. Critical biological processes affected by the combined changes in cell shape and signal transduction include cell migration, proliferation, transformation and apoptosis, making the elucidation of the mechanisms involved of considerable interest. HEF1, and the related proteins p130Cas and Efs/Sin, define the Cas (Crk-associated substrate) family of focal adhesion-associated signaling proteins. Mechanistic studies of these proteins has defined their roles in the processes of cell adhesion and cell migration, and outlined a set of upstream inducers and downstream mediators of their function. However, our work has also demonstrated that HEF1 possesses additional unique activities relevant to apoptosis and cell division. These discrete activities derive from the function of processed forms of HEF1. A 28 kD carboxyterminal form induces cellular rounding and initiates p53-dependent death signaling under some growth circumstances, opposing a pro-survival activity of p130Cas. Intriguingly, a 55 kD aminoterminal HEF1 form arising in mitosis translocates to the mitotic spindle; and we have recently determined that altering the expression level and ratios between different forms of HEF1 so as to increase abundance of full length HEF1 versus the 55 kD form results in a failure of mitosis that involves development of multipolar spindles, failure of abscission at cytokinesis, and accumulation of cells at G1. This suite of defects is compatible with defects reported for proteins involved in functions at the centrosome, based on activities that include regulation of cyclin B stability, and licensing of abscission through centrosomal migration to the site of cytokinesis and delivery of proteins such as p160ROCK that control actomyosin ring contractile function. We have also determined that endogenous HEF1 localizes to the centrosome, and further shown that mis-expressed HEF1 affects cyclin B accumulation and activation of RhoA, a p160ROCK activator. Based on these and other results, we propose that HEF1 has a unique function as a regulator of cell cycle progression through mitosis and cytokinesis, and that this effect is separable from its roles in attachment-related survival signaling. Our goal is to determine whether HEF1 uses common or unique effectors for its functions in interphase versus mitotic cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways
-
批准号:10651045
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2023
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development
-
批准号:10590604
-
项目类别:
-
资助金额:$15.18万
-
财政年份:2022
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development
-
批准号:10333087
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2022
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Targeting asymmetric ciliary signaling in cancer
-
批准号:9751534
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2019
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Multiplexing biomarker analyzer
-
批准号:9075947
-
项目类别:
-
资助金额:$7.59万
-
财政年份:2016
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Interaction of protein-targeted therapeutics and ciliary dynamics
-
批准号:9337444
-
项目类别:
-
资助金额:$40.16万
-
财政年份:2016
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Interaction of protein-targeted therapeutics and ciliary dynamics
-
批准号:9927617
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2016
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Msi2 regulates the aggressiveness of Non-Small Cell Lung Cancer (NSCLC)
-
批准号:9264497
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2016
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Interaction of protein-targeted therapeutics and ciliary dynamics
-
批准号:9142856
-
项目类别:
-
资助金额:$11.6万
-
财政年份:2015
-
负责人:ERICA A. GOLEMIS
-
依托单位:
A Role for AMH Autocrine Signaling in NSCLC
-
批准号:8887314
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2014
-
负责人:ERICA A. GOLEMIS
-
依托单位:
A Role for AMH Autocrine Signaling in NSCLC
-
批准号:8756117
-
项目类别:
-
资助金额:$19.11万
-
财政年份:2014
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Cas Protein Regulation of EMT in Cancer
-
批准号:8102942
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2007
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Cas Protein Regulation of EMT in Cancer
-
批准号:7321244
-
项目类别:
-
资助金额:$29.21万
-
财政年份:2007
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Cas Protein Regulation of EMT in Cancer
-
批准号:7671269
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2007
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Cas Protein Regulation of EMT in Cancer
-
批准号:7479093
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2007
-
负责人:ERICA A. GOLEMIS
-
依托单位:
HIF-1
-
批准号:7602894
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2007
-
负责人:ERICA A. GOLEMIS
-
依托单位:
Cas Protein Regulation of EMT in Cancer
-
批准号:7892384
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2007
-
负责人:ERICA A. GOLEMIS
-
依托单位:
HIF-1
-
批准号:7183197
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2005
-
负责人:ERICA A. GOLEMIS
-
依托单位:
HIF-1
-
批准号:6979148
-
项目类别:
-
资助金额:$7.09万
-
财政年份:2004
-
负责人:ERICA A. GOLEMIS
-
依托单位:
HEI C AND MORPHOGENESIS AND SIGNALING
-
批准号:6633363
-
项目类别:
-
资助金额:$26.31万
-
财政年份:1999
-
负责人:ERICA A. GOLEMIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
miR-30c-5p通过MTDH/HIF-1α/PKM2环形反馈抑制乳腺癌进展的作用及机制研究
-
批准号:JCZRLH202600025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIF-1α-FtL信号轴通过调控神经元铁稳态抑制NLRP3炎性小体活化在脑缺血再灌注损伤中的作用与机制研究
-
批准号:JCZRLH202600706
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肿瘤相关成纤维细胞通过分泌COL10A1 介导HIF1α/KLF5调控肝细胞癌上皮间质转化和血管生成拟态的机制研究
-
批准号:JCZRLH202602031
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIF-1α介导H3K18乳酸化调控石榴皮多酚改善痤疮皮脂代谢紊乱机制研究
-
批准号:2026JJ60632
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王云
-
依托单位:
HIF1-α/PKM2调控糖酵解-STING组蛋白乳酸化介导小胶质细胞训练免疫在应激性认知功能障碍中的作用及机制
-
批准号:2026JJ50024
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭思杰
-
依托单位:
基于HIF-1α乳酸化修饰探讨桃红四物汤调控BMSCs-H型血管新生轴促进骨折愈合的分子机制研究
-
批准号:2026JJ80362
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周新
-
依托单位:
糖尿病肾病肾纤维化改善新机制:SIRT3/HIF-1α维持足细胞脂代谢抑制细胞焦亡
-
批准号:2026JJ82303
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘润芝
-
依托单位:
降脂消斑片通过HIF-1α/PKM2信号通路介导的能量代谢重编程抑制巨噬细胞铁死亡治疗动脉粥样硬化的作用机制
-
批准号:2026JJ60305
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张杼惠
-
依托单位:
基于HIF-1αVEGFMMPs信号通路研究经筋弹拨法改善KOA大鼠骨破坏的研究
-
批准号:2026JJ80645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡金鲁
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位: